Myosite orbitaire associée à un traitement par ipilimumab

M Lecouflet; M Verschoore; C Giard; P Gohier; Y Le Corre; D Milea; L Martin

doi:10.1016/j.annder.2013.02.029

Myosite orbitaire associée à un traitement par ipilimumab

M Lecouflet, M Verschoore, C Giard, P Gohier, Y Le Corre, D Milea, L Martin

Afdeling for Øjensygdomme

41 Citationer (Scopus)

Abstract

Ipilimumab is a monoclonal antibody targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) that allows increased survival and, occasionally, complete remission, in the treatment of metastatic melanoma. The most frequent adverse effects are attributed to dysimmunity. We report the case of a female patient who developed orbital myositis during treatment with ipilimumab.

Bidragets oversatte titel	Orbital myositis associated with ipilimumab
Originalsprog	Fransk
Tidsskrift	Annales de Dermatologie et de Venereologie
Vol/bind	140
Udgave nummer	6-7
Sider (fra-til)	448-51
Antal sider	4
ISSN	0151-9638
DOI	https://doi.org/10.1016/j.annder.2013.02.029
Status	Udgivet - 2013

Emneord

Aged
Antibodies, Monoclonal
Antineoplastic Agents
CD4-Positive T-Lymphocytes
CTLA-4 Antigen
Cavernous Sinus Thrombosis
Cellulitis
Combined Modality Therapy
Diagnosis, Differential
Diplopia
Exophthalmos
Female
Foot Diseases
Humans
Immunotherapy
Lymphatic Metastasis
Melanoma
Orbital Myositis
Skin Neoplasms

Adgang til dokumentet

10.1016/j.annder.2013.02.029

Citationsformater

@article{55aeebb8e6f74a28bee868c79da055c8,

title = "Myosite orbitaire associ{\'e}e {\`a} un traitement par ipilimumab",

abstract = "Ipilimumab is a monoclonal antibody targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) that allows increased survival and, occasionally, complete remission, in the treatment of metastatic melanoma. The most frequent adverse effects are attributed to dysimmunity. We report the case of a female patient who developed orbital myositis during treatment with ipilimumab.",

keywords = "Aged, Antibodies, Monoclonal, Antineoplastic Agents, CD4-Positive T-Lymphocytes, CTLA-4 Antigen, Cavernous Sinus Thrombosis, Cellulitis, Combined Modality Therapy, Diagnosis, Differential, Diplopia, Exophthalmos, Female, Foot Diseases, Humans, Immunotherapy, Lymphatic Metastasis, Melanoma, Orbital Myositis, Skin Neoplasms",

author = "M Lecouflet and M Verschoore and C Giard and P Gohier and {Le Corre}, Y and D Milea and L Martin",

year = "2013",

doi = "10.1016/j.annder.2013.02.029",

language = "Fransk",

volume = "140",

pages = "448--51",

journal = "Annales de Dermatologie et de Venereologie",

issn = "0151-9638",

publisher = "Elsevier Masson Editeur",

number = "6-7",

}

TY - JOUR

T1 - Myosite orbitaire associée à un traitement par ipilimumab

AU - Lecouflet, M

AU - Verschoore, M

AU - Giard, C

AU - Gohier, P

AU - Le Corre, Y

AU - Milea, D

AU - Martin, L

PY - 2013

Y1 - 2013

N2 - Ipilimumab is a monoclonal antibody targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) that allows increased survival and, occasionally, complete remission, in the treatment of metastatic melanoma. The most frequent adverse effects are attributed to dysimmunity. We report the case of a female patient who developed orbital myositis during treatment with ipilimumab.

AB - Ipilimumab is a monoclonal antibody targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) that allows increased survival and, occasionally, complete remission, in the treatment of metastatic melanoma. The most frequent adverse effects are attributed to dysimmunity. We report the case of a female patient who developed orbital myositis during treatment with ipilimumab.

KW - Aged

KW - Antibodies, Monoclonal

KW - Antineoplastic Agents

KW - CD4-Positive T-Lymphocytes

KW - CTLA-4 Antigen

KW - Cavernous Sinus Thrombosis

KW - Cellulitis

KW - Combined Modality Therapy

KW - Diagnosis, Differential

KW - Diplopia

KW - Exophthalmos

KW - Female

KW - Foot Diseases

KW - Humans

KW - Immunotherapy

KW - Lymphatic Metastasis

KW - Melanoma

KW - Orbital Myositis

KW - Skin Neoplasms

U2 - 10.1016/j.annder.2013.02.029

DO - 10.1016/j.annder.2013.02.029

M3 - Tidsskriftartikel

C2 - 23773743

SN - 0151-9638

VL - 140

SP - 448

EP - 451

JO - Annales de Dermatologie et de Venereologie

JF - Annales de Dermatologie et de Venereologie

IS - 6-7

ER -

Myosite orbitaire associée à un traitement par ipilimumab

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater